Boston is built on research. Your audience needs to hear it.
I help Boston founders in biotech, healthtech, edtech, and deep tech turn dense, credentialed expertise into short-form that real people watch and trust. Remote studio, real distribution.
Few cities have a denser concentration of expertise than Boston. MIT and Harvard feed a deep-tech and biotech pipeline, the hospital systems anchor a serious healthtech scene, and edtech has deep roots here too. The founders are PhDs, MDs, and career researchers, so credibility is rarely the issue. The issue is reach. Brilliant science communicated badly converts nobody, and a lot of Boston founders quietly believe that simplifying their work means cheapening it. It does not. The most trusted voices in biotech and healthtech are the ones who can explain something genuinely hard in a way a smart non-specialist can follow. That is a skill, and it is exactly what I build. I run a remote content and distribution studio that takes your rigorous, credentialed expertise and shapes it into short-form that earns trust fast and travels far, without ever sanding off the substance that makes you worth listening to.
Reach compounding once the engine is running on cadence.
I get exactly where you're stuck
Boston runs on rigor. Labs, hospitals, universities, the deep-tech spinouts that come out of them. The founders here are some of the most credentialed in the country, which is the blessing and the problem. The credibility is sky-high and the communication is often impenetrable. I take the rigor and make it land without dumbing it down.
Your work is too dense to spread
Boston founders speak in the language of their field, which is perfect for peers and useless for everyone else. Investors, hires, patients, and partners bounce off it. I help you keep the rigor and lose the wall.
You think simplifying means selling out
There is a real fear in this market that clear equals shallow. It does not. The most respected people in your field are the ones who explain hard things clearly. I help you become one of them without compromising the science.
Long sales and regulatory cycles need constant trust
Biotech and healthtech deals take years and trust has to be rebuilt at every stage. If you only show up at raises and milestones, the trust goes cold. Consistent content keeps you credible the entire long road.
The engine, step by step
- 01
Unpack the science
We sit down and I work to genuinely understand what you do, then find the angle that makes it gripping to people outside your field. The rigor stays, the wall comes down.
- 02
Translate into a hook
We script each piece so the hard idea opens with something a smart non-specialist actually cares about, then earns its depth. Clear, credible, never cheap.
- 03
Produce for trust
We cut clean, substantive short-form and carousels formatted for LinkedIn and YouTube, where Boston's credentialed audiences make their judgments.
- 04
Sustain and compound
We post on a consistent cadence built for long cycles, tracking what resonates with investors and partners and reinforcing the threads that build standing in your field.
The system behind the content
One shoot day turning into a stack of assets every month.
Translate without dumbing down
We take your hardest concept and find the explanation that a smart outsider can follow, keeping every bit of the substance. That clarity is the differentiator in a field full of jargon, and it makes you the one people quote.
Build for credibility-driven platforms
Boston's audiences, investors, clinicians, academics, partners, live on LinkedIn and long-form YouTube. We script and cut for those, where a thoughtful, credentialed voice carries the most weight.
Compound trust over the long cycle
Because your sales cycles are measured in years, we run a steady cadence that keeps you present and credible between milestones, so when the moment to decide arrives you are already the trusted name in the room.
With the engine vs going it alone
- Rigorous expertise translated so smart outsiders actually get it
- Built for LinkedIn and YouTube, where credentialed buyers decide
- A steady presence that keeps trust warm across multi-year cycles
- A founder voice that becomes the quotable authority in the field
- World-class science that never escapes the lab or the deck
- Communication so dense partners and patients bounce off it
- Trust that goes cold between raises and clinical milestones
- Watching less rigorous competitors out-explain you and win
of expertise, finally made watchable
rigor kept, zero dumbing down
inbound from investors and partners
of trust built between milestones
Boston founders are the smartest room I work in and often the most reluctant on camera. There is a deep instinct here that the work should speak for itself, that promotion is beneath the science. I understand it, and I think it quietly costs this city. Because the work does not speak for itself, someone has to speak for it, and if you will not, a less rigorous competitor with a louder voice will define the category instead. My job is not to turn a researcher into a salesperson. It is to take someone who has spent fifteen years going deep on something that genuinely matters and help them say it in a way the world can hear. The first time we do it, most of my Boston clients are stunned by how it feels to finally be understood by people outside their field. Investors lean in, recruits reach out, partners start the conversation already trusting you. In a city this credentialed, the founders who learn to communicate clearly do not just get heard, they get to define what their field believes.
The kind of result I'm after
What results tend to look like here: a founder who only surfaced at funding announcements starts publishing clear, rigorous short-form and finds investors and potential partners reaching out warm instead of cold. Recruits cite the content as the reason they applied. Comment threads fill with clinicians and researchers, the audience that matters. Over a few months the founder becomes a name people quote in their corner of biotech or healthtech, and the long sales cycle moves faster because trust was being built the whole time rather than only at the milestones.
For Boston, the core engine is translation: taking dense, credentialed expertise and making it watchable without losing the science. We extract your hardest concepts, script them with hooks a smart outsider can follow, and cut clean short-form and carousels for LinkedIn and YouTube. Add repurposing of talks and publications, plus a consistent cadence built for multi-year biotech, healthtech, and deep-tech cycles. Everything is calibrated for an audience that judges on credibility. You keep doing the rigorous work. I make sure the people who need to trust it actually understand it.